Tissue plasminogen activator: Mechanisms and clinical significance
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Tissue plasminogen activator (tPA) is a glycoprotein involved in the breakdown of the blood clots. It is a serine protease (EC 3.4.21.68) found on endothelial cells, the cells that line the blood vessels. It catalyzes the conversion of plasminogen to plasmin, the major enzyme responsible for clot breakdown. t-PA is synthesized mainly in vascular endothelial cells and is secreted into the plasma continuously and also through the acute release of t-PA. t-PA is a 68 k Da serine protease composed of 530 amino acids. t-PA is used in some cases of diseases that feature blood clots, such as pulmonary embolism, myocardial infarction, and stroke. Therefore, it is necessary to produce thrombolytic medications that are more effective, more focused, affordable, and secure. Although further studies are required to establish downstream processes that will be required to enable medical applications.
Fields of Study & Subjects
Blood Coagulation and Thrombosis Mechanisms
Protease and Inhibitor Mechanisms
Blood properties and coagulation
Publication details
- Journal / source
- International Journal of Advanced Biochemistry Research
- Volume
- 10
- Issue
- 3
- Pages
- 788–795
- Publication date
- 1 March 2026
- Language
- EN